Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Contact information


olivier.zanier@oncology.ox.ac.uk


ResearchGate


ORCID ID 0000-0002-3286-3770


Old Road Campus Research Building, Roosevelt Drive, Oxford, UK

Research groups

College



Olivier Zanier

MMed

DPhil student

Research

I investigate novel treatment agents for paediatric high-grade gliomas (pHGG), highly aggressive brain tumours in children for which very limited therapeutic options exist. My work focuses on ROS-inducing agents and hypoxia-activated compounds that leverage tumour hypoxia and oxidative stress, for which there is emerging evidence in the pHGG microenvironment.

My research is supervised by Prof Hammond and Dr Olcina. It is part of HIT-GLIO, an international consortium of researchers dedicated to enhancing the quality of life for pHGG patients and their families.

My studies are generously supported by the University of Oxford through a Clarendon Fund Scholarship and a Medical Sciences Postgraduate Studentship.

Biography

Before moving to Oxford, I studied medicine at the University of Zurich in Switzerland, where my research as part of the MICN-Lab focused on the intersection of neurosurgery and machine learning. As a physician-scientist, I aim to bridge the gap between research and clinical application with the goal of ultimately advancing patient care for neuro-oncological patients.

Connect

Recent publications